RAI3 was initially considered to be a potential tumour-suppressor gene because of its presumed regulation by retinoids, which have shown to influence tumourigenesis and exert significant therapeutic and preventative effects on tumours. The gene discussed is GPRC5A; the disease is neoplasm.